openPR Logo
Press release

Humanized Mice Model Market to total US$ 182.0 Million by 2034, Expanding at a 6.0% CAGR- Fact.MR Study

05-28-2025 12:24 PM CET | Health & Medicine

Press release from: Fact.MR

Humanized Mice Model Market

Humanized Mice Model Market

The global humanized mice model market value is anticipated to reach US$ 101.6 million by 2024. The market is expected to grow at a CAGR of 6.0% and reach a size of US$ 182.0 million by 2034. The mice model market is growing because of the growing demand for personalized treatment and a widening pipeline of pharmaceutical & biopharmaceutical companies.

Precision medicine is gaining popularity among cancer patients due to increasing uses of genetic profiling for the diagnosis and treatment of various tumor types. The demand for mice models is anticipated to increase with the increased demand for precision medicine in the market.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9627 

Humanized Mice Model Market Trends

Humanized mice models are often used in preclinical drug development to assess the safety and efficacy of potential treatments. Demand for the models is likely to increase as pharmaceutical and biotechnology companies seek more realistic models of human biology on which to try out new medicines.

More advanced gene editing methods like CRISPR/Cas9 have enabled the generation of humanized mice models with higher precision and speed. This trend accelerated model generation and improved disease modeling in humans.

Country-wise Insights

China's market is expected to register incredible growth, exhibiting a stellar CAGR of 6.7% during 2034. The growth is mainly driven due to the rising demand for humanized mice models across major countries. The United States leads the humanized mice model market, growing at a CAGR of 5.9% by 2034.

United States humanized mouse model market is projected to achieve a CAGR of 5.9% during 2034. Academic and research institutes are the major consumers of humanized mice models in United States. By utilizing these models in various study areas, these institutes facilitate an enhancement in consumer's awareness about human diseases and potential cures.

Category-wise Insights

According to the model type, the cell-based segment is forecasted to grow at a CAGR of 6.1% by 2034. At the same time, the genetic segment is expected to increase at 5.9% CAGR by 2034. According to application, the oncology segment records its leadership in the market for humanized mice models at a CAGR of 6.2% by 2034.

Why Are Cell-based Humanized Mice Models Preferentially Used?

"Growing Need to Analyze Therapeutic Strategies with Cell-based Models"

By model type, the cell-based segment is anticipated to boom at a CAGR of 6.1% through 2034. Cell-based models play a significant role in the market for humanized mice models and assist with advancing numerous disciplines, such as immunology, infectious diseases, cancer, and personalized medicine.

By the transplantation or injection of human cells into immunodeficient mice, these models allow researchers to study disease, therapies, and responses unique to humans.

Humanized mouse models with human cells engrafted are commonly used in oncology studies. They generate an in vivo environment that closely replicates human physiology and allows researchers to study tumor growth, metastasis, and anticancer medication response.

Competitive Landscape

Key companies in the market of humanized mice models are THE JACKSON LABORATORY, laconic Biosciences, Inc., Genoway S.A., Yecuris Corporation, Charles River Laboratories, Inc., Crown Bioscience Inc., Ingenious Targeting Laboratory Inc., orizon Discovery Group plc, HuMurine Technologies, and Trans Genic Inc., Ltd.

The market of humanized mice models has a changing competitive environment. Top companies are emphasizing research & development and new products to increase their market share.

Major players are further focusing on green practices and product certifications and meeting the growing demand for customized drugs. Top players are maintaining their market position and riding the growing demand by being concerned with the quality and innovation of the product.

For example,

In October 2021, The Jackson Laboratory (JAX), a non-profit biomedical research institution in the United States, purchased Charles River Laboratories Japan's Research Models & Services (RMS) business as a wholly-owned subsidiary.

In February 2019, H.I.G. Capital LLC, through one of its affiliates, purchased Taconic Biosciences Inc.

In November 2020, The Jackson Laboratory and Beijing Anitec Biotechnology launched a joint venture partnership for enhancing access and velocity to superior quality research models and services in China.

Browse Full Report: https://www.factmr.com/report/humanized-mice-model-market

Humanized Mice Model Market Segmentation by Category

By Model Type:
Genetic
Cell-based
CD-34
PBMC
By Application:
Toxicology
Oncology
Infectious Disease
GvHD
Regenerative Medicine
Neurobiology
Others
By End-user:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic & Research Institutes
By Region:
North America
Latin America
Eastern Europe
Western Europe
South Asia and the Pacific
East Asia
Middle East and Africa

Check out More Related Studies Published by Fact.MR:

Capillary Blood Collection Devices Market
https://www.factmr.com/report/capillary-blood-collection-devices-market
Plasma Fractionation Market
https://www.factmr.com/report/4806/plasma-fractionation-market
Tooth Filling Materials Market
https://www.factmr.com/report/tooth-filling-materials-market
Voice Prosthesis Devices Market
https://www.factmr.com/report/voice-prosthesis-devices-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Humanized Mice Model Market to total US$ 182.0 Million by 2034, Expanding at a 6.0% CAGR- Fact.MR Study here

News-ID: 4040244 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Model

Animal Model Market
The Global Animal Model Market, detailed in the TechSci Research report titled, "Animal Model Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028," exhibited a value of USD 1.67 billion in 2022, poised to grow at a Compound Annual Growth Rate (CAGR) of 7.64% from 2024 to 2028. This comprehensive analysis delves into the intricate web of factors driving the market, including the global burden of chronic
Executing a Business Model Transformation with A Business Model Canvas
Business model transformation is the process of changing the way a company operates, with the aim of improving its overall performance. This transformation often involves significant changes to a company's existing business model. To ensure that the transformation process is successful, companies can use a tool called the business model canvas. Get a free business model canvas here: https://digitalleadership.com/unite-articles/extended-business-model-canvas/ Steps in Executing a Business Model Transformation with A Business Model Canvas Business
Fourth Party Logistics Market : Industry Innovator Model, Solution Integrator Mo …
The fourth party logistics market was valued at $57.9 billion in 2021, and is estimated to reach $111.7 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031. Fourth party logistics, popularly known as 4PL, is the model of outsourcing of logistics operations, where the service provider integrates with the company's supply chain department. This logistics partner is responsible for assessing, designing, building, running, and measuring integrated supply
How Drizly Works: Business Model & Revenue Model
‘Slow and steady wins the race.’ Such is the case with the world’s leading alcohol marketplace, Drizly which carved a unique, step-by-step growth strategy for itself and eventually, succeeded in transforming the way alcohol is bought and sold across various continents. Co-founded in 2012 by Cory Rellas and Nick Rellas, the Boston-based start-up which was one of the first few on-demand liquor delivery apps to make its way into the market,
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Cloud Computing in Healthcare Market By Deployment Model (Public- cloud deployme …
Industry Outlook and Trend Analysis The Cloud Computing in Healthcare Market was worth USD 3.05 billion in 2014 and is expected to reach approximately USD 16.25 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 20.43% during the forecast period. Cloud computing, commonly alluded to as 'the cloud', is a technique to access and store the information and projects over the internet. The cloud computing is